GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SMS Pharmaceuticals Ltd (BOM:532815) » Definitions » Cash-to-Debt

SMS Pharmaceuticals (BOM:532815) Cash-to-Debt : N/A (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is SMS Pharmaceuticals Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. SMS Pharmaceuticals's cash to debt ratio for the quarter that ended in Dec. 2023 was N/A.

The historical rank and industry rank for SMS Pharmaceuticals's Cash-to-Debt or its related term are showing as below:

BOM:532815' s Cash-to-Debt Range Over the Past 10 Years
Min: 0   Med: 0.07   Max: 0.18
Current: 0.14

During the past 13 years, SMS Pharmaceuticals's highest Cash to Debt Ratio was 0.18. The lowest was 0.00. And the median was 0.07.

BOM:532815's Cash-to-Debt is ranked worse than
81.55% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs BOM:532815: 0.14

SMS Pharmaceuticals Cash-to-Debt Historical Data

The historical data trend for SMS Pharmaceuticals's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

SMS Pharmaceuticals Cash-to-Debt Chart

SMS Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.06 0.16 0.18 0.03

SMS Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.03 N/A 0.14 N/A

Competitive Comparison of SMS Pharmaceuticals's Cash-to-Debt

For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMS Pharmaceuticals's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where SMS Pharmaceuticals's Cash-to-Debt falls into.



SMS Pharmaceuticals Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

SMS Pharmaceuticals's Cash to Debt Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

SMS Pharmaceuticals's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SMS Pharmaceuticals  (BOM:532815) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


SMS Pharmaceuticals Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of SMS Pharmaceuticals's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


SMS Pharmaceuticals (BOM:532815) Business Description

Traded in Other Exchanges
Address
Plot No. 72, H.No. 8-2-334/3&4, Road. No. 5, Opposite SBI Executive Enclave, Banjara Hills, Hyderabad, TG, IND, 500034
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.

SMS Pharmaceuticals (BOM:532815) Headlines

No Headlines